These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 10048430

  • 41. Central nervous system relapse in non-Hodgkin lymphoma. A single-center study of 532 patients.
    Bollen EL, Brouwer RE, Hamers S, Hermans J, Kluin M, Sankatsing SU, A-Tjak RV, Charvat MV, Kluin-Nelemans JC.
    Arch Neurol; 1997 Jul; 54(7):854-9. PubMed ID: 9236574
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. TNF-α increases in the CSF of children with acute lymphoblastic leukemia before CNS relapse.
    Jaime-Pérez JC, Gamboa-Alonso CM, Jiménez-Castillo RA, López-Silva LJ, Pinzón-Uresti MA, Gómez-De León A, Gómez-Almaguer D.
    Blood Cells Mol Dis; 2017 Mar; 63():27-31. PubMed ID: 28061377
    [Abstract] [Full Text] [Related]

  • 44. Risk factors of central nervous system relapse in mantle cell lymphoma.
    Conconi A, Franceschetti S, Lobetti-Bodoni C, Stathis A, Margiotta-Casaluci G, Ramponi A, Mazzucchelli L, Bertoni F, Ghielmini M, Gaidano G, Cavalli F, Zucca E.
    Leuk Lymphoma; 2013 Sep; 54(9):1908-14. PubMed ID: 23339449
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Primary Central Nervous System Lymphoma-PART 1: Epidemiology, Diagnosis, Staging, and Prognosis.
    Lukas RV, Stupp R, Gondi V, Raizer JJ.
    Oncology (Williston Park); 2018 Jan 15; 32(1):17-22. PubMed ID: 29447417
    [Abstract] [Full Text] [Related]

  • 47. CNS involvement in small noncleaved-cell lymphoma: is CNS disease per se a poor prognostic sign?
    Haddy TB, Adde MA, Magrath IT.
    J Clin Oncol; 1991 Nov 15; 9(11):1973-82. PubMed ID: 1941056
    [Abstract] [Full Text] [Related]

  • 48. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
    Sancho JM, Ribera JM, Oriol A, Hernandez-Rivas JM, Rivas C, Bethencourt C, Parody R, Deben G, Bello JL, Feliu E, Programa para el Estudio y Tratamiento de Hemopatias Malignas Group.
    Cancer; 2006 Jun 15; 106(12):2540-6. PubMed ID: 16700036
    [Abstract] [Full Text] [Related]

  • 49. The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study.
    Hasegawa D, Manabe A, Ohara A, Kikuchi A, Koh K, Kiyokawa N, Fukushima T, Ishida Y, Saito T, Hanada R, Tsuchida M, Tokyo Children's Cancer Study Group.
    Pediatr Blood Cancer; 2012 Jan 15; 58(1):23-30. PubMed ID: 21254378
    [Abstract] [Full Text] [Related]

  • 50. [Treatment results and the prognosis in patients with localization of non-Hodgkins-lymphoma in the central nervous system].
    Paulus JA, Bos GM, Löwenberg B, Van Den Bent MJ.
    Ned Tijdschr Geneeskd; 1998 Oct 03; 142(40):2196-200. PubMed ID: 9864481
    [Abstract] [Full Text] [Related]

  • 51. [Clinical Characteristics and Prognosis of 21 Cases of Acute Lymphoblastic Leukemia with Central Nervous System Leukemia].
    Jin XS, Yang L, Wang BH, Li HH, Yu L, Jing Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec 03; 24(6):1675-1682. PubMed ID: 28024476
    [Abstract] [Full Text] [Related]

  • 52. Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.
    Tai WM, Chung J, Tang PL, Koo YX, Hou X, Tay KW, Quek R, Tao M, Lim ST.
    Ann Hematol; 2011 Jul 03; 90(7):809-18. PubMed ID: 21229246
    [Abstract] [Full Text] [Related]

  • 53. To protect and defend: central nervous system prophylaxis in patients with non-Hodgkin's lymphoma.
    Lim HY, Thiel E, Glantz MJ.
    Curr Opin Oncol; 2008 Sep 03; 20(5):495-501. PubMed ID: 19106650
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report.
    Doolittle ND, Abrey LE, Shenkier TN, Tali S, Bromberg JE, Neuwelt EA, Soussain C, Jahnke K, Johnston P, Illerhaus G, Schiff D, Batchelor T, Montoto S, Kraemer DF, Zucca E.
    Blood; 2008 Feb 01; 111(3):1085-93. PubMed ID: 17962515
    [Abstract] [Full Text] [Related]

  • 56. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Guo J, Zhu YP, Gao J, Li Q, Jia CS, Zhou CY, Guo X.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb 01; 24(1):72-9. PubMed ID: 26913397
    [Abstract] [Full Text] [Related]

  • 57. Involvement of the central nervous system by non-Hodgkin's lymphoma in adults. A review of 36 cases.
    Mead GM, Kennedy P, Smith JL, Thompson J, Macbeth FR, Ryall RD, Williams CJ, Whitehouse JM.
    Q J Med; 1986 Jul 01; 60(231):699-714. PubMed ID: 3763820
    [Abstract] [Full Text] [Related]

  • 58. Phase II study of cytarabine and etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: a study of the French Society of Pediatric Oncology.
    Gentet JC, Patte C, Quintana E, Bergeron C, Rubie H, Pein F, Demaille MC, Philip T, Raybaud C.
    J Clin Oncol; 1990 Apr 01; 8(4):661-5. PubMed ID: 2313335
    [Abstract] [Full Text] [Related]

  • 59. Childhood non-Hodgkin's lymphoma involving the testis: clinical features and treatment outcome.
    Kellie SJ, Pui CH, Murphy SB.
    J Clin Oncol; 1989 Aug 01; 7(8):1066-70. PubMed ID: 2666589
    [Abstract] [Full Text] [Related]

  • 60. Aggressive chemotherapy in the treatment of Burkitt's and non-Burkitt's undifferentiated lymphoma.
    Mazza JJ, Hines JD, Andersen JW, Neiman RS, Mann R, Oken MM, O'Connell MJ.
    Leuk Lymphoma; 1995 Jul 01; 18(3-4):289-96. PubMed ID: 8535195
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.